{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:40:51Z","timestamp":1789681251884,"version":"4.0.1"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.npep.2023.102335","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T19:58:55Z","timestamp":1679687935000},"page":"102335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Orexin receptor antagonists in the pathophysiology and treatment of sleep disorders and epilepsy"],"prefix":"10.1016","volume":"99","author":[{"given":"Mohammad","family":"Sheibani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Shayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Khalilzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Reza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2023.102335_bb0005","first-page":"66","article-title":"Unilateral hypothalamus inactivation prevents PTZ kindling development through hippocampal orexin receptor 1 modulation","volume":"5","author":"Akbari","year":"2014","journal-title":"Bas. Clin. Neurosci."},{"key":"10.1016\/j.npep.2023.102335_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12868-018-0445-9","article-title":"The effect of intracerebroventricular administration of orexin receptor type 2 antagonist on pentylenetetrazol-induced kindled seizures and anxiety in rats","volume":"19","author":"Asadi","year":"2018","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.npep.2023.102335_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11920-017-0775-9","article-title":"Cannabis, cannabinoids, and sleep: a review of the literature","volume":"19","author":"Babson","year":"2017","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.npep.2023.102335_bb0020","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1528-1167.2008.01784.x","article-title":"Effect of sleep stage on interictal high-frequency oscillations recorded from depth macroelectrodes in patients with focal epilepsy","volume":"50","author":"Bagshaw","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.npep.2023.102335_bb0025","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/npp.2011.310","article-title":"Differential effects of a dual orexin receptor antagonist (SB-649868) and zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power spectra in a model of situational insomnia","volume":"37","author":"Bettica","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.npep.2023.102335_bb0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1600-0404.1997.tb00097.x","article-title":"A quantitative study of daytime sleepiness induced by carbamazepine and add-on vigabatrin in epileptic patients","volume":"95","author":"Bonanni","year":"1997","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.npep.2023.102335_bb0035","doi-asserted-by":"crossref","first-page":"12531","DOI":"10.3390\/ijms222212531","article-title":"Sleep disruption worsens seizures: neuroinflammation as a potential mechanistic link","volume":"22","author":"Bonilla-Jaime","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.npep.2023.102335_bb0040","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1528-1157.1976.tb04447.x","article-title":"Has sodium valproate hypnotic effects?","volume":"17","author":"Boxer","year":"1976","journal-title":"Epilepsia"},{"key":"10.1016\/j.npep.2023.102335_bb0045","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1523\/JNEUROSCI.22-07-02862.2002","article-title":"Direct and indirect excitation of laterodorsal tegmental neurons by hypocretin\/orexin peptides: implications for wakefulness and narcolepsy","volume":"22","author":"Burlet","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2023.102335_bb0050","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1152\/japplphysiol.00700.2012","article-title":"A unified survival theory of the functioning of the hypocretinergic system","volume":"115","author":"Chase","year":"2013","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.npep.2023.102335_bb0055","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/med.21326","article-title":"The hypocretin\/orexin system: an increasingly important role in neuropsychiatry","volume":"35","author":"Chen","year":"2015","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.npep.2023.102335_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135097","article-title":"The role of orexin-a levels in epileptic seizure","volume":"734","author":"\u00c7ikriklar","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2023.102335_bb0065","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0167-0115(01)00357-3","article-title":"Protein distribution of the orexin-2 receptor in the rat central nervous system","volume":"104","author":"Cluderay","year":"2002","journal-title":"Regul. Pept."},{"key":"10.1016\/j.npep.2023.102335_bb0070","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0006-8993(70)90447-6","article-title":"Sleep stages, REM deprivation and electroconvulsive threshold in the cat","volume":"19","author":"Cohen","year":"1970","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2023.102335_bb0075","series-title":"Sleep Physiology, Sleep Disorders and Sleep Deprivation: An Unmet Public Health Problem","author":"Colten","year":"2006"},{"key":"10.1016\/j.npep.2023.102335_bb0080","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1021\/jm100541c","article-title":"Discovery of the dual orexin receptor antagonist [(7 R)-4-(5-chloro-1, 3-benzoxazol-2-yl)-7-methyl-1, 4-diazepan-1-yl][5-methyl-2-(2 H-1, 2, 3-triazol-2-yl) phenyl] methanone (MK-4305) for the treatment of insomnia","volume":"53","author":"Cox","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.npep.2023.102335_bb0085","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"De Lecea","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.npep.2023.102335_bb0090","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.pharmthera.2004.10.015","article-title":"Erratum to \u201ccellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintenance of epilepsy\u201d[Pharmacol. Ther. 105 (3)(2005) 229\u2013266]","volume":"111","author":"DeLorenzo","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.npep.2023.102335_bb0095","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.44.11.2060","article-title":"Epilepsy and sleep apnea syndrome","volume":"44","author":"Devinsky","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.npep.2023.102335_bb0100","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/epi.12631","article-title":"Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders","volume":"55","author":"Devinsky","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.npep.2023.102335_bb0105","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/sleep\/18.4.252","article-title":"Sleep deprivation and spike-wave discharges in epileptic rats","volume":"18","author":"Drinkenburg","year":"1995","journal-title":"Sleep"},{"key":"10.1016\/j.npep.2023.102335_bb0110","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4103\/0976-500X.155496","article-title":"Suvorexant: the first orexin receptor antagonist to treat insomnia","volume":"6","author":"Dubey","year":"2015","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.npep.2023.102335_bb0115","doi-asserted-by":"crossref","first-page":"9273","DOI":"10.1523\/JNEUROSCI.21-23-09273.2001","article-title":"Orexin\/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus","volume":"21","author":"Eriksson","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2023.102335_bb0120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.peptides.2012.06.012","article-title":"Orexins cause epileptic activity","volume":"37","author":"Erken","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2023.102335_bb0125","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/B978-0-12-394623-2.00011-1","article-title":"Glutamate and orexin neurons","volume":"89","author":"Eyigor","year":"2012","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.npep.2023.102335_bb0130","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the global burden of disease study 2016","volume":"18","author":"Feigin","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.npep.2023.102335_bb0135","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.npep.2023.102335_bb0140","first-page":"117","article-title":"The insomnia-addiction positive feedback loop: role of the orexin system. The orexin system","volume":"45","author":"Fragale","year":"2021","journal-title":"Bas. Sci. Pathol."},{"key":"10.1016\/j.npep.2023.102335_bb0145","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/epi.13389","article-title":"EEG desynchronization during phasic REM sleep suppresses interictal epileptic activity in humans","volume":"57","author":"Frauscher","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.npep.2023.102335_bb0150","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1177\/0883073811435916","article-title":"Effect of melatonin on seizure frequency in intractable epilepsy: a pilot study","volume":"27","author":"Goldberg-Stern","year":"2012","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.npep.2023.102335_bb0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pbb.2015.01.006","article-title":"Hippocampal orexin receptors inactivation reduces PTZ induced seizures of male rats","volume":"130","author":"Goudarzi","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.npep.2023.102335_bb0160","series-title":"Epilepsy and Other Chronic Convulsive Diseases: Their Causes, Symptoms, and Treatment","author":"Gowers","year":"1901"},{"key":"10.1016\/j.npep.2023.102335_bb0165","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/MCP.0000000000000101","article-title":"Sleep disorders in adults with epilepsy: past, present, and future directions","volume":"20","author":"Grigg-Damberger","year":"2014","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.npep.2023.102335_bb0170","series-title":"The Epilepsy Handbook: The Practical Management of Seizures","author":"Gumnit","year":"1995"},{"key":"10.1016\/j.npep.2023.102335_bb0175","doi-asserted-by":"crossref","first-page":"10911","DOI":"10.1073\/pnas.96.19.10911","article-title":"Orexin a activates locus coeruleus cell firing and increases arousal in the rat","volume":"96","author":"Hagan","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.npep.2023.102335_bb0180","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1523\/JNEUROSCI.3258-04.2005","article-title":"The wake-promoting peptide orexin-B inhibits glutamatergic transmission to dorsal raphe nucleus serotonin neurons through retrograde endocannabinoid signaling","volume":"25","author":"Haj-Dahmane","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2023.102335_bb0185","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.1109\/JSEN.2019.2907664","article-title":"Real-time epileptic seizure detection during sleep using passive infrared sensors","volume":"19","author":"Hanosh","year":"2019","journal-title":"IEEE Sensors J."},{"key":"10.1016\/j.npep.2023.102335_bb0190","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0896-6273(01)00293-8","article-title":"Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity","volume":"30","author":"Hara","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.npep.2023.102335_bb0195","doi-asserted-by":"crossref","DOI":"10.4103\/abr.abr_262_16","article-title":"Beneficial effects of selective orexin-a receptor antagonist in 4-aminopyridine-induced seizures in male rats","volume":"6","author":"Hayatdavoudi","year":"2017","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.npep.2023.102335_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.1056706","article-title":"Selective activation of the hypothalamic orexinergic but not melanin-concentrating hormone neurons following pilocarpine-induced seizures in rats","volume":"16","author":"He","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.npep.2023.102335_bb0205","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.12782","article-title":"Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications","volume":"28","author":"Herring","year":"2019","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.npep.2023.102335_bb0210","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0306-4522(01)00033-1","article-title":"Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord","volume":"103","author":"Hervieu","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2023.102335_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025076","article-title":"Orexin neurons receive glycinergic innervations","volume":"6","author":"Hondo","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.npep.2023.102335_bb0220","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0006-8993(99)01131-2","article-title":"Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats","volume":"821","author":"Ida","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2023.102335_bb0225","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fendo.2013.00018","article-title":"The physiological role of orexin\/hypocretin neurons in the regulation of sleep\/wakefulness and neuroendocrine functions","volume":"4","author":"Inutsuka","year":"2013","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.npep.2023.102335_bb0230","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1097\/00001756-200006050-00031","article-title":"Hypocretin\/orexin depolarizes and decreases potassium conductance in locus coeruleus neurons","volume":"11","author":"Ivanov","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.npep.2023.102335_bb0235","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.5664\/jcsm.7282","article-title":"An update on dual orexin receptor antagonists and their potential role in insomnia therapeutics","volume":"14","author":"Janto","year":"2018","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.npep.2023.102335_bb0240","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1528-1157.1962.tb05235.x","article-title":"The grand Mai \u00e9pilepsies and the sleeping-waking cycle","volume":"3","author":"Janz","year":"1962","journal-title":"Epilepsia"},{"key":"10.1016\/j.npep.2023.102335_bb0245","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3389\/fneur.2020.00327","article-title":"Epilepsy and its interaction with sleep and circadian rhythm","volume":"11","author":"Jin","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.npep.2023.102335_bb0250","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1113\/jphysiol.2002.038729","article-title":"Intravenously administered hypocretin-1 alters brain amino acid release: an in vivo microdialysis study in rats","volume":"548","author":"John","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.npep.2023.102335_bb0255","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1210\/endo.142.8.8299","article-title":"Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats","volume":"142","author":"J\u00f6hren","year":"2001","journal-title":"Endocrinology"},{"issue":"18\u201323","key":"10.1016\/j.npep.2023.102335_bb0260","article-title":"Cannabidiol treatment for refractory seizures in Sturge-weber syndrome","volume":"71","author":"Kaplan","year":"2017","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.npep.2023.102335_bb0265","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1113\/jphysiol.2010.198457","article-title":"Direct and indirect control of orexin\/hypocretin neurons by glycine receptors","volume":"589","author":"Karnani","year":"2011","journal-title":"J. Physiol."},{"key":"10.1016\/j.npep.2023.102335_bb0270","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.peptides.2008.09.023","article-title":"Electrophysiological effects of orexins\/hypocretins on pedunculopontine tegmental neurons in rats: an in vitro study","volume":"30","author":"Kim","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2023.102335_bb0275","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.3389\/fnins.2021.790546","article-title":"In vivo evidence for brain region-specific molecular interactions between cannabinoid and orexin receptors","volume":"15","author":"Kim","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.npep.2023.102335_bb0280","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/npr2.12205","article-title":"Evidence-based insomnia treatment strategy using novel orexin antagonists: a review","volume":"41","author":"Kishi","year":"2021","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.npep.2023.102335_bb0285","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0196-9781(02)00109-2","article-title":"Arousal effects of orexin-a correlate with GLU release from the locus coeruleus in rats","volume":"23","author":"Kodama","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2023.102335_bb0290","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsac238","article-title":"Dual orexin antagonist normalized sleep homeostatic drive, enhanced GABAergic inhibition, and suppressed seizures after traumatic brain injury","volume":"45","author":"Konduru","year":"2022","journal-title":"Sleep"},{"key":"10.1016\/j.npep.2023.102335_bb0295","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/fcp.12249","article-title":"SB-334867, an orexin receptor 1 antagonist, decreased seizure and anxiety in pentylenetetrazol-kindled rats","volume":"31","author":"Kordi Jaz","year":"2017","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.npep.2023.102335_bb0300","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.peptides.2012.02.013","article-title":"Orexins increase penicillin-induced epileptic activity","volume":"34","author":"Kortunay","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2023.102335_bb0305","series-title":"Seminars in Pediatric Neurology","first-page":"42","article-title":"The relationship between sleep and epilepsy","author":"Kotagal","year":"2008"},{"key":"10.1016\/j.npep.2023.102335_bb0310","doi-asserted-by":"crossref","first-page":"21876","DOI":"10.4088\/JCP.13011su1c","article-title":"Understanding the sleep-wake cycle: sleep, insomnia, and the orexin system","volume":"74","author":"Krystal","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.npep.2023.102335_bb0315","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/bph.12324","article-title":"Orexin\/hypocretin receptor signalling cascades","volume":"171","author":"Kukkonen","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2023.102335_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.smrv.2016.09.004","article-title":"Suvorexant for the treatment of primary insomnia: a systematic review and meta-analysis","volume":"35","author":"Kuriyama","year":"2017","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.npep.2023.102335_bb0325","first-page":"453","article-title":"Sleep and epilepsy: a complex interplay","volume":"114","author":"Lanigar","year":"2017","journal-title":"Mo. Med."},{"key":"10.1016\/j.npep.2023.102335_bb0330","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.chest.2022.04.151","article-title":"Cannabinoids, insomnia, and other sleep disorders","volume":"162","author":"Lavender","year":"2022","journal-title":"Chest."},{"key":"10.1016\/j.npep.2023.102335_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.107993","article-title":"The hypocretin (orexin) system: from a neural circuitry perspective","volume":"167","author":"Li","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2023.102335_bb0340","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1523\/JNEUROSCI.4015-04.2005","article-title":"Direct and indirect inhibition by catecholamines of hypocretin\/orexin neurons","volume":"25","author":"Li","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2023.102335_bb0345","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0896-6273(02)01132-7","article-title":"Hypocretin\/orexin excites hypocretin neurons via a local glutamate neuron\u2014a potential mechanism for orchestrating the hypothalamic arousal system","volume":"36","author":"Li","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.npep.2023.102335_bb0350","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/bph.12415","article-title":"The hypocretins\/orexins: integrators of multiple physiological functions","volume":"171","author":"Li","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2023.102335_bb0355","doi-asserted-by":"crossref","first-page":"9453","DOI":"10.1523\/JNEUROSCI.22-21-09453.2002","article-title":"Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions","volume":"22","author":"Liu","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2023.102335_bb0360","article-title":"Effect of add-on melatonin on seizure outcomes and quality of sleep in epilepsy with idiopathic generalized tonic-clonic seizures alone in adult patients: Cross-sectional, randomized, double-blind, placebo-controlled clinical trial","volume":"e2860","author":"Maghbooli","year":"2023","journal-title":"Brain Behav."},{"key":"10.1016\/j.npep.2023.102335_bb0365","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ncl.2005.07.002","article-title":"Sleep and epilepsy","volume":"23","author":"Malow","year":"2005","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.npep.2023.102335_bb0370","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1528-1167.2007.01400.x","article-title":"The interaction between sleep and epilepsy","volume":"48","author":"Malow","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.npep.2023.102335_bb0375","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.sleep.2003.06.004","article-title":"Identification and treatment of obstructive sleep apnea in adults and children with epilepsy: a prospective pilot study","volume":"4","author":"Malow","year":"2003","journal-title":"Sleep Med."},{"key":"10.1016\/j.npep.2023.102335_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41927-020-00148-1","article-title":"Association of lifestyle elements with self-rated wellness and health status in patients with Behcet's disease","volume":"4","author":"Masoumi","year":"2020","journal-title":"BMC Rheumatol."},{"key":"10.1016\/j.npep.2023.102335_bb0385","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1073\/pnas.0811126106","article-title":"Selective loss of GABAB receptors in orexin-producing neurons results in disrupted sleep\/wakefulness architecture","volume":"106","author":"Matsuki","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.npep.2023.102335_bb0390","doi-asserted-by":"crossref","first-page":"9687","DOI":"10.1523\/JNEUROSCI.23-29-09687.2003","article-title":"Sleep deprivation causes behavioral, synaptic, and membrane excitability alterations in hippocampal neurons","volume":"23","author":"McDermott","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2023.102335_bb0395","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40263-012-0036-8","article-title":"Orexin (hypocretin) receptor agonists and antagonists for treatment of sleep disorders: rationale for development and current status","volume":"27","author":"Mieda","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.npep.2023.102335_bb0400","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1073\/pnas.0400590101","article-title":"Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice","volume":"101","author":"Mieda","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.npep.2023.102335_bb0405","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fendo.2013.00057","article-title":"Differential roles of orexin receptors in the regulation of sleep\/wakefulness","volume":"4","author":"Mieda","year":"2013","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.npep.2023.102335_bb0410","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1212\/WNL.50.2_Suppl_1.S16","article-title":"Genetic and familial aspects of narcolepsy","volume":"50","author":"Mignot","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.npep.2023.102335_bb0415","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1042\/BJ20041745","article-title":"The sustainability of interactions between the orexin-1 receptor and \u03b2-arrestin-2 is defined by a single C-terminal cluster of hydroxy amino acids and modulates the kinetics of ERK MAPK regulation","volume":"387","author":"Milasta","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.npep.2023.102335_bb0420","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/sleep\/25.8.56","article-title":"Relationship of epileptic seizures to sleep stage and sleep depth","volume":"25","author":"Minecan","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.npep.2023.102335_bb0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039131","article-title":"Dual hypocretin receptor antagonism is more effective for sleep promotion than antagonism of either receptor alone","volume":"7","author":"Morairty","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.npep.2023.102335_bb0430","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1523\/JNEUROSCI.1027-04.2004","article-title":"Serotonergic regulation of the orexin\/hypocretin neurons through the 5-HT1A receptor","volume":"24","author":"Muraki","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2023.102335_bb0435","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2174\/1871527318666191021143300","article-title":"Cannabidiol partially blocks the excessive sleepiness in Hypocretin-deficient rats: preliminary data","volume":"18","author":"Murillo-Rodr\u00edguez","year":"2019","journal-title":"CNS & Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.npep.2023.102335_bb0440","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.peptides.2010.04.029","article-title":"Cytosolic calcium elevation induced by orexin\/hypocretin in granule cell domain cells of the rat cochlear nucleus in vitro","volume":"31","author":"Nakamura","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2023.102335_bb0445","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1059131102001723","article-title":"A paradoxical effect of levetiracetam may be seen in both children and adults with refractory epilepsy","volume":"12","author":"Nakken","year":"2003","journal-title":"Seizure"},{"key":"10.1016\/j.npep.2023.102335_bb0450","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsw061","article-title":"Orexin and epilepsy: potential role of REM sleep","volume":"40","author":"Ng","year":"2017","journal-title":"Sleep"},{"key":"10.1016\/j.npep.2023.102335_bb0455","series-title":"Epilepsy Research and Treatment","first-page":"2013","article-title":"Why are seizures rare in rapid eye movement sleep? Review of the frequency of seizures in different sleep stages","author":"Ng","year":"2013"},{"key":"10.1016\/j.npep.2023.102335_bb0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2018.03.021","article-title":"Rapid eye movement sleep behavior disorder or epileptic seizure during sleep? A video analysis of motor events","volume":"58","author":"Nguyen-Michel","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.npep.2023.102335_bb0465","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10072-013-1495-5","article-title":"Pentylenetetrazol-induced seizures are exacerbated by sleep deprivation through orexin receptor-mediated hippocampal cell proliferation","volume":"35","author":"Ni","year":"2014","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.npep.2023.102335_bb0470","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.arr.2014.11.001","article-title":"Sleep disorders, obesity, and aging: the role of orexin","volume":"20","author":"Nixon","year":"2015","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.npep.2023.102335_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108341","article-title":"Expert opinion: managing sleep disturbances in people with epilepsy","volume":"124","author":"Nobili","year":"2021","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.npep.2023.102335_bb0480","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13622","article-title":"Sleep and epilepsy: a snapshot of knowledge and future research lines","volume":"31","author":"Nobili","year":"2022","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.npep.2023.102335_bb0485","first-page":"239","article-title":"Novel class of medications, orexin receptor antagonists, in the treatment of insomnia\u2013critical appraisal of suvorexant","author":"Norman","year":"2016","journal-title":"Nat. Sci. Sleep"},{"key":"10.1016\/j.npep.2023.102335_bb0490","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrn895","article-title":"The neurobiology of sleep: genetics, cellular physiology and subcortical networks","volume":"3","author":"Pace-Schott","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.npep.2023.102335_bb0495","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13628","article-title":"Sleep, insomnia and mental health","volume":"31","author":"Palagini","year":"2022","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.npep.2023.102335_bb0500","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/epi.16785","article-title":"Identifying seizure risk factors: a comparison of sleep, weather, and temporal features using a Bayesian forecast","volume":"62","author":"Payne","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.npep.2023.102335_bb0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2003.09.032","article-title":"Increased hypocretin-1 levels in cerebrospinal fluid after REM sleep deprivation","volume":"995","author":"Pedrazzoli","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2023.102335_bb0510","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2023.102335_bb0515","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.nrleng.2019.07.008","article-title":"Insomnia and poor sleep quality are associated with poor seizure control in patients with epilepsy","volume":"37","author":"Planas-Ballve","year":"2022","journal-title":"Neurolog\u00eda (English Edition)"},{"key":"10.1016\/j.npep.2023.102335_bb0520","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0960-894X(01)00343-2","article-title":"1, 3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptor","volume":"11","author":"Porter","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.npep.2023.102335_bb0525","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1528-1157.1993.tb02598.x","article-title":"Correlations between night sleep duration and seizure frequency in temporal lobe epilepsy","volume":"34","author":"Rajna","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.npep.2023.102335_bb0530","first-page":"383","article-title":"Suvorexant, a dual orexin receptor antagonist, protected seizure through interaction with GABAA and glutamate receptors","volume":"19","author":"Razavi","year":"2020","journal-title":"Iran. J. Pharma. Res."},{"key":"10.1016\/j.npep.2023.102335_bb0535","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1111\/j.1528-1167.2008.01990.x","article-title":"Decreased cerebrospinal fluid hypocretin-1 (orexin a) in patients after repetitive generalized tonic\u2013clonic seizures","volume":"50","author":"Rejdak","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.npep.2023.102335_bb0540","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/2042098615595359","article-title":"Suvorexant in insomnia: efficacy, safety and place in therapy","volume":"6","author":"Rhyne","year":"2015","journal-title":"Therap. Adv. Drug Safety"},{"key":"10.1016\/j.npep.2023.102335_bb0545","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1474-4422(13)70311-9","article-title":"Orexin receptor antagonists: a new treatment for insomnia?","volume":"13","author":"Riemann","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.npep.2023.102335_bb0550","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-0404.2008.01004.x","article-title":"Benzodiazepines in epilepsy: pharmacology and pharmacokinetics","volume":"118","author":"Riss","year":"2008","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.npep.2023.102335_bb0555","doi-asserted-by":"crossref","first-page":"357","DOI":"10.5665\/sleep.5444","article-title":"Orexin receptor antagonism improves sleep and reduces seizures in Kcna1-null mice","volume":"39","author":"Roundtree","year":"2016","journal-title":"Sleep"},{"key":"10.1016\/j.npep.2023.102335_bb0560","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.smrv.2004.07.007","article-title":"Roles of orexin\/hypocretin in regulation of sleep\/wakefulness and energy homeostasis","volume":"9","author":"Sakurai","year":"2005","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.npep.2023.102335_bb0565","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrn2092","article-title":"The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness","volume":"8","author":"Sakurai","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.npep.2023.102335_bb0570","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.tips.2011.03.007","article-title":"Connectomics of orexin-producing neurons: interface of systems of emotion, energy homeostasis and arousal","volume":"32","author":"Sakurai","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.npep.2023.102335_bb0575","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.npep.2023.102335_bb0580","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.3390\/jcm9103354","article-title":"Decreased cerebrospinal fluid orexin-a (Hypocretin-1) concentrations in patients after generalized convulsive status epilepticus","volume":"9","author":"Samzadeh","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.npep.2023.102335_bb0585","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/nature04284","article-title":"Hypothalamic regulation of sleep and circadian rhythms","volume":"437","author":"Saper","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.npep.2023.102335_bb0590","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev-pharmtox-010510-100528","article-title":"Orexin receptors: pharmacology and therapeutic opportunities","volume":"51","author":"Scammell","year":"2011","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.npep.2023.102335_bb0595","doi-asserted-by":"crossref","first-page":"12437","DOI":"10.1523\/JNEUROSCI.0706-12.2012","article-title":"Optogenetic probing of fast glutamatergic transmission from hypocretin\/orexin to histamine neurons in situ","volume":"32","author":"Sch\u00f6ne","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2023.102335_bb0600","first-page":"615","article-title":"The neurobiology of sleep and wakefulness","volume":"38","author":"Schwartz","year":"2015","journal-title":"Psychiatr. Clin."},{"key":"10.1016\/j.npep.2023.102335_bb0605","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.neuroscience.2004.05.012","article-title":"Orexins\/hypocretins cause sharp wave-and \u03b8-related synaptic plasticity in the hippocampus via glutamatergic, gabaergic, noradrenergic, and cholinergic signaling","volume":"127","author":"Selbach","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2023.102335_bb0610","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/cells11010171","article-title":"Lithium and erectile dysfunction: an overview","volume":"11","author":"Sheibani","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.npep.2023.102335_bb0615","first-page":"R1114","article-title":"Orexin depolarizes rat hypothalamic paraventricular nucleus neurons","volume":"281","author":"Shirasaka","year":"2001","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"key":"10.1016\/j.npep.2023.102335_bb0620","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3390\/molecules24081459","article-title":"Use of cannabidiol in the treatment of epilepsy: efficacy and security in clinical trials","volume":"24","author":"Silvestro","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.npep.2023.102335_bb0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33425\/2639-944X.1089","article-title":"Mechanisms of association of sleep and metabolic syndrome","volume":"3","author":"Smiley","year":"2019","journal-title":"J. Med. Clin. Res. Rev."},{"key":"10.1016\/j.npep.2023.102335_bb0630","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.lfs.2016.02.075","article-title":"SB 334867, a selective orexin receptor type 1 antagonist, elevates seizure threshold in mice","volume":"150","author":"Soca\u0142a","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.npep.2023.102335_bb0635","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0028-3908(01)00156-3","article-title":"SB-334867-A antagonises orexin mediated excitation in the locus coeruleus","volume":"42","author":"Soffin","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2023.102335_bb0640","article-title":"Evolution of orexin neuropeptide system: structure and function","volume":"691","author":"Soya","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.npep.2023.102335_bb0645","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuroscience.2011.08.033","article-title":"Aging-related alterations in orexin\/hypocretin modulation of septo-hippocampal amino acid neurotransmission","volume":"195","author":"Stanley","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2023.102335_bb0650","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1365-2125.2006.02680.x","article-title":"Drugs for sleep disorders: mechanisms and therapeutic prospects","volume":"61","author":"Szabadi","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.npep.2023.102335_bb0655","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0013-4694(75)90045-0","article-title":"Kindling effect and sleep organization in cats","volume":"39","author":"Tanaka","year":"1975","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.npep.2023.102335_bb0660","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","article-title":"Reduced number of hypocretin neurons in human narcolepsy","volume":"27","author":"Thannickal","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.npep.2023.102335_bb0665","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/pr.109.001321","article-title":"Orexin\/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system","volume":"61","author":"Tsujino","year":"2009","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.npep.2023.102335_bb0670","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12031-011-9526-2","article-title":"Orexins\/hypocretins acting at G i protein-coupled OX 2 receptors inhibit cyclic AMP synthesis in the primary neuronal cultures","volume":"46","author":"Urba\u0144ska","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.npep.2023.102335_bb0675","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1523\/JNEUROSCI.18-19-07962.1998","article-title":"Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin\/orexin","volume":"18","author":"van den Pol","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2023.102335_bb0680","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1059-1311(96)80066-5","article-title":"Improvement of epileptic seizure control with treatment of obstructive sleep apnoea","volume":"5","author":"Vaughn","year":"1996","journal-title":"Seizure"},{"key":"10.1016\/j.npep.2023.102335_bb0685","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev.med.50.1.387","article-title":"Sleep and its disorders","volume":"50","author":"Vgontzas","year":"1999","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.npep.2023.102335_bb0690","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3390\/biom11081134","article-title":"Identification and characterization of cannabidiol as an OX1R antagonist by computational and in vitro functional validation","volume":"11","author":"Vitale","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.npep.2023.102335_bb0695","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fnmol.2018.00220","article-title":"The orexin\/receptor system: molecular mechanism and therapeutic potential for neurological diseases","volume":"11","author":"Wang","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.npep.2023.102335_bb0700","doi-asserted-by":"crossref","first-page":"11439","DOI":"10.1523\/JNEUROSCI.3459-04.2004","article-title":"Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response","volume":"24","author":"Winsky-Sommerer","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2023.102335_bb0705","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1152\/jn.00035.2005","article-title":"Direct excitation of hypocretin\/orexin cells by extracellular ATP at P2X receptors","volume":"94","author":"Wollmann","year":"2005","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.npep.2023.102335_bb0710","doi-asserted-by":"crossref","first-page":"7754","DOI":"10.1523\/JNEUROSCI.22-17-07754.2002","article-title":"Hypocretin increases impulse flow in the septohippocampal GABAergic pathway: implications for arousal via a mechanism of hippocampal disinhibition","volume":"22","author":"Wu","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2023.102335_bb0715","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1523\/JNEUROSCI.5364-03.2004","article-title":"Hypocretin\/orexin innervation and excitation of identified septohippocampal cholinergic neurons","volume":"24","author":"Wu","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2023.102335_bb0720","article-title":"The relationship between sleep quality and the severity of insomnia with the frequency of seizures in epileptic patients","volume":"4","author":"Wuysang","year":"2021","journal-title":"Med. Cl\u00edn. Pr\u00e1ct."},{"key":"10.1016\/j.npep.2023.102335_bb0725","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1113\/jphysiol.2006.108266","article-title":"GABAB receptor-mediated modulation of hypocretin\/orexin neurones in mouse hypothalamus","volume":"574","author":"Xie","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.npep.2023.102335_bb0730","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0896-6273(03)00331-3","article-title":"Hypothalamic orexin neurons regulate arousal according to energy balance in mice","volume":"38","author":"Yamanaka","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.npep.2023.102335_bb0735","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0006-291X(03)00299-7","article-title":"Regulation of orexin neurons by the monoaminergic and cholinergic systems","volume":"303","author":"Yamanaka","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.npep.2023.102335_bb0740","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.tips.2006.05.006","article-title":"The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions","volume":"27","author":"Zeitzer","year":"2006","journal-title":"Trends Pharmacol. Sci."}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417923000161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417923000161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T20:39:05Z","timestamp":1758919145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417923000161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":148,"alternative-id":["S0143417923000161"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2023.102335","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orexin receptor antagonists in the pathophysiology and treatment of sleep disorders and epilepsy","name":"articletitle","label":"Article Title"},{"value":"Neuropeptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npep.2023.102335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102335"}}